Celsion Corporation Announces Issuance of New Patent for ThermoDox®
17 avr. 2019 08h00 HE
|
Celsion CORP
Represents a Significant Advance for Celsion’s Life Cycle Management Program for ThermoDox® Establishing Bioequivalence Will Extend Market Exclusivity to 2033 LAWRENCEVILLE, N.J,...
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
15 nov. 2012 07h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012
13 nov. 2012 13h34 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...